Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuping Yin

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Biomaterials|February 17, 2026
PANoptosis-triggering GA-based biomimetic nano-prodrug remodels the tumor microenvironment to enhance antitumor immunityFeiyang Shen, Yijia Wu, Tianhao Li, et al.
Inflammopharmacology|July 20, 2023
Immune Response Gene-1 [IRG1]/itaconate protect against multi-organ injury via inhibiting gasdermin D-mediated pyroptosis and inflammatory responseWenchang Yang, Yaxin Wang, Yongzhou Huang, et al.
Scientific Reports|September 1, 2023
Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosisYongzhou Huang, Wenchang Yang, Lei Yang, et al.
Annals of Surgical Oncology|November 19, 2025
ASO Visual Abstract: Oxidative Stress Inflammation Score is the Optimal Inflammatory Prognostic Indicator for Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant Immunochemotherapy: A Multicenter Retrospective Cohort StudyTianhao Li, Jianing Ding, Xuanfei Li, et al.
International Journal of Biological Sciences|September 17, 2019
BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP InhibitorPeng Zhang, Ruidong Li, Hua Xiao, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 11, 2024
Which surrogate endpoint best predict survival in locally advanced gastric cancer patients undergoing neoadjuvant chemoimmunotherapy followed by surgery? A multicenter retrospective studyXiong Sun, Xuanfei Li, Shijun Zhao, et al.
BMC Surgery|March 20, 2024
Interleukin-6 on postoperative day three as an early predictor of infections following laparoscopic gastric cancer resectionYongzhou Huang, Lei Yang, Wenchang Yang, et al.
Frontiers in Immunology|May 22, 2023
Safety and efficacy of tislelizumab plus chemotherapy versus chemotherapy alone as neoadjuvant treatment for patients with locally advanced gastric cancer: real-world experience with a consecutive patient cohortQi Jiang, Weizhen Liu, Xiangyu Zeng, et al.
World Journal of Surgical Oncology|August 17, 2022
Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapyQi Jiang, Xiangyu Zeng, Chenggang Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 11, 2018
EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axisShaofei Chen, Jiarui Pu, Jie Bai, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Biomaterials|February 17, 2026
PANoptosis-triggering GA-based biomimetic nano-prodrug remodels the tumor microenvironment to enhance antitumor immunityFeiyang Shen, Yijia Wu, Tianhao Li, et al.
Inflammopharmacology|July 20, 2023
Immune Response Gene-1 [IRG1]/itaconate protect against multi-organ injury via inhibiting gasdermin D-mediated pyroptosis and inflammatory responseWenchang Yang, Yaxin Wang, Yongzhou Huang, et al.
Scientific Reports|September 1, 2023
Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosisYongzhou Huang, Wenchang Yang, Lei Yang, et al.
Annals of Surgical Oncology|November 19, 2025
ASO Visual Abstract: Oxidative Stress Inflammation Score is the Optimal Inflammatory Prognostic Indicator for Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant Immunochemotherapy: A Multicenter Retrospective Cohort StudyTianhao Li, Jianing Ding, Xuanfei Li, et al.
International Journal of Biological Sciences|September 17, 2019
BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP InhibitorPeng Zhang, Ruidong Li, Hua Xiao, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 11, 2024
Which surrogate endpoint best predict survival in locally advanced gastric cancer patients undergoing neoadjuvant chemoimmunotherapy followed by surgery? A multicenter retrospective studyXiong Sun, Xuanfei Li, Shijun Zhao, et al.
BMC Surgery|March 20, 2024
Interleukin-6 on postoperative day three as an early predictor of infections following laparoscopic gastric cancer resectionYongzhou Huang, Lei Yang, Wenchang Yang, et al.
Frontiers in Immunology|May 22, 2023
Safety and efficacy of tislelizumab plus chemotherapy versus chemotherapy alone as neoadjuvant treatment for patients with locally advanced gastric cancer: real-world experience with a consecutive patient cohortQi Jiang, Weizhen Liu, Xiangyu Zeng, et al.
World Journal of Surgical Oncology|August 17, 2022
Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapyQi Jiang, Xiangyu Zeng, Chenggang Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 11, 2018
EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axisShaofei Chen, Jiarui Pu, Jie Bai, et al.
Pageof 7